Amorepacific invests in Junevity for next-gen skin rejuvenation
Bridging Biology and Beauty: Amorepacific Teams Up with Biotechnology Innovator to Redefine Skin Rejuvenation
The quest for truly transformative skincare is getting a massive upgrade. Amorepacific, a titan in the cosmetics industry, has joined forces with biotechnology company Junevity to embark on a pioneering mission: developing next-generation beauty products rooted in advanced skin biology and cutting-edge AI.
This strategic collaboration is not just about launching new products; it is about fundamentally rethinking how we approach skin aging. The partnership aims to harness the power of genetic and biological research to identify the fundamental pathways that govern skin aging, seeking to find methods to reset those aging gene networks toward a healthier state.
At the heart of this innovation is Junevity’s powerful RESET Platform. This sophisticated technology leverages human disease omics, genetic linkages, and machine learning and AI to pinpoint crucial transcription factor targets—the specific biological switches that control skin aging.
By integrating Junevity’s deep biological insights with Amorepacific’s unparalleled expertise in skin biology, cosmetic development, and commercialization, the two entities are creating a synergistic engine for discovery. Amorepacific will lead the charge in developing and commercializing products derived from this research, focusing on tangible, effective results for consumers.
While Amorepacific focuses on the cosmetic application, Junevity continues to pursue the therapeutic potential of its technology, advancing research into novel treatment applications.
This joint venture solidifies Amorepacific’s commitment to longevity-focused skin science. It represents a bold pivot, weaving the complex world of biotechnology, artificial intelligence, and gene-network research directly into the heart of cosmetic R&D, promising a future where beauty is guided by precision biological science.
Buy on Amazon
Credit
